APMD

APMD · Apnimed Inc. Common Stock

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 15, 2026

Apnimed to Present Five Abstracts at CHEST 2026. Apnimed announced it will present five abstracts, including two late-breaking studies, at the CHEST 2026 conference. This highlights the company's ongoing research activity and clinical data generation. The stock currently trades well below its 52-week high, with an average analyst target of $50.33.

this person other insiders at APMD

Insiders & Stakes

Alpha Wave Ventures GP, Ltd
10% Owner
7,054,956
Shares held
Miller Lawrence G.88,954
Shares held
Morningside Venture Investments Ltd
10% Owner
75,624
Shares held
Molnar Dennis Patrick
President
58,014
Shares held
Paul J. Sekhri
Director
12,500
Shares held

Transaction History

Morningside Venture Investments Ltd▼ Sell—
Morningside Venture Investments Ltd▼ Sell—
Morningside Venture Investments Ltd▲ Buy$5.0M
Morningside Venture Investments Ltd▼ Sell—
Morningside Venture Investments Ltd▼ Sell—
Alpha Wave Ventures GP, Ltd▼ Sell—
Alpha Wave Ventures GP, Ltd▼ Sell—
Alpha Wave Ventures GP, Ltd▼ Sell—
Alpha Wave Ventures GP, Ltd▼ Sell$20.4M
Paul J. Sekhri▲ Buy$200K
Miller Lawrence G.▼ Sell—
Miller Lawrence G.▲ Buy—
Miller Lawrence G.▼ Sell—
Miller Lawrence G.▲ Buy—
Miller Lawrence G.▼ Sell—
Miller Lawrence G.▲ Buy—
Miller Lawrence G.▼ Sell—
Miller Lawrence G.▲ Buy—
Miller Lawrence G.▼ Sell—
Miller Lawrence G.▲ Buy—
Molnar Dennis Patrick▼ Sell—
Molnar Dennis Patrick▲ Buy—
Miller Lawrence G.▼ Sell—
Morningside Venture Investments Ltd▼ Sell$1.1M
Morningside Venture Investments Ltd▼ Sell—

We use analytics to understand how market-wall is used. No personal data is sold.